Business
Health Catalyst Announces ~$5 Million Stock Repurchase
Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million.
About this update from Health Catalyst, Inc
[{"type":"text","content":"SALT LAKE CITY, March 11, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced it has repurchased shares of its common stock ("Common Stock") in an aggregate amount of approximately $5 million.","length":353,"tagName":"p"},{"type":"image","alt":"(PRNewsfoto/Health Catalyst)","displaySize":"","headline":null,"caption":"(PRNewsfoto/Health Catalyst)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":72,"url":"https://media.zenfs.com/en/prnewswire.com/02aea701f4e618c5741ef0564ece20c6"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UXzyKNlK5xDdcpTSTh2huw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEyNztjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/02aea701f4e618c5741ef0564ece20c6","width":400,"height":72}},"href":"https://mma.prnewswire.com/media/1323666/Health_Catalyst_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"These repurchased shares were acquired between March 3, 2025, and March 10, 2025, as part of Health Catalyst's existing share repurchase program approved by its board of directors on August 2, 2022, which authorized repurchases of up to $40 million of Common Stock. These recent repurchases resulted in the retirement of approximately 1.1 million shares of Common Stock.","length":374,"tagName":"p"},{"type":"text","content":""Our repurchase of shares underscores our confidence in the future of our business," said Dan Burton, CEO of Health Catalyst. "We believe the current market does not reflect the long-term value of our shares of common stock, including our anticipated continued achievement of operating leverage and our reacceleration of revenue growth. This repurchase demonstrates our continued commitment to creating long-term, sustainable value for our shareholders, our clients, and our team members."","length":514,"tagName":"p"},{"type":"text","content":"About Health CatalystHealth Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst's offerings, includ...